Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 2006

Sort by

Sort Order Select

Journal Articles

TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas

Pierre Stephan, Roberta Di Blasi, Louise Roulin, Jean Galtier, Julien Calvani, Véronique Meignin, Marie Donzel, Alexandra Traverse-Glehen, Elsa Poullot, Marie Parrens, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Roch Houot, Francois-Xavier Gros, François Lemonnier, Emmanuel Bachy, Catherine Thieblemont, Pierre Sesques

Blood Adv (2025) 9 (18): 4693–4704.

https://doi.org/10.1182/bloodadvances.2025015834

Published: 2025

Includes: Supplemental data

Journal Articles

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia

Blood Adv (2025) 9 (18): 4568–4579.

https://doi.org/10.1182/bloodadvances.2025016513

Published: 2025

Journal Articles

Efficacy and safety of BCMA nanobody CAR T-cell therapy in relapsed or refractory plasma cell myeloma

Xian G. Zhang, Lin Wang, Junfang Yang, Xiaona N. Hu, Hui Wang, Lina N. Zhang, Xiaoge Zhou, Ying Liu, Qinglong Wang, Peihua H. Lu

Blood Adv (2025) 9 (18): 4543–4552.

https://doi.org/10.1182/bloodadvances.2025016322

Published: 2025

Includes: Supplemental data

Journal Articles

Asciminib for relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia

Blood Adv (2025) 9 (18): 4580–4584.

https://doi.org/10.1182/bloodadvances.2025016665

Published: 2025

Includes: Supplemental data

Journal Articles

Age-adjusted dosing of fludarabine for lymphodepletion in CAR T-cell therapy: a clinical trial simulation study

John C. Panetta, Aimee C. Talleur, Swati Naik, Stephen Gottschalk, Markos Leggas

Blood Adv (2025) 9 (18): 4676–4682.

https://doi.org/10.1182/bloodadvances.2025015928

Published: 2025

Includes: Supplemental data

Journal Articles

Bing-Neel syndrome: a case series of 46 patients from the United Kingdom

Oliver Tomkins, Jahanzaib Khwaja, Shiwen Koay, Nicole Japzon, Chandrashekar Hoskote, Rajeev Gupta, Robert Baker, Jindriska Lindsay, Charalampia Kyriakou, Michael P. Lunn, Shirley D’Sa

Blood Adv (2025) 9 (18): 4614–4617.

https://doi.org/10.1182/bloodadvances.2025016360

Published: 2025

Journal Articles

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis

Alberto Guijosa, Andres Ramirez-Gamero, Shayna Sarosiek, Andrew R. Branagan, Gottfried von Keudell, Steven P. Treon, Jorge J. Castillo

Blood Adv (2025) 9 (18): 4705–4715.

https://doi.org/10.1182/bloodadvances.2025016536

Published: 2025

Journal Articles

A standardized metric to define a successful transition from pediatric to adult care in sickle cell disease

Galia Pollock, Susanna Curtis

Blood Adv (2025) 9 (18): 4622–4623.

https://doi.org/10.1182/bloodadvances.2025017088

Published: 2025

Journal Articles

Risk Biomarkers of Chronic Graft-versus-host disease in Children aged 10 years or younger and Children/adults Older than 10 years

Anna Crawford Ferreira, Debjani Dutta, Courtney M Rowan, Jamie Renbarger, Kenneth R Cooke, Paul A. Carpenter, Robert A Krance, Christine N Duncan, Conrad Russell Y. Cruz, David A Jacobsohn, Catherine M. Bollard, Elizabeth Hill, Sophie Paczesny

Blood Adv bloodadvances.2025016624.

https://doi.org/10.1182/bloodadvances.2025016624

Published: 2025

Includes: Supplemental data

Journal Articles

Overall survival, conditioning, and MRD in MORPHO

Gege Gui, Christopher S Hourigan

Blood Adv bloodadvances.2025017937.

https://doi.org/10.1182/bloodadvances.2025017937

Published: 2025

Journal Articles

Outcomes following transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from ASPEN

Ramon Garcia-Sanz, Roger G. Owen, Wojciech Jurczak, Meletios Athanasios Dimopoulos, Helen McCarthy, Gavin Cull, Stephen S. Opat, Jorge J. Castillo, Marie José Kersten, Björn E. Wahlin, Sebastian Grosicki, Radha Prathikanti, Tian Tian, Heather Allewelt, Aileen Cohen, Constantine S. Tam

Blood Adv bloodadvances.2024015596.

https://doi.org/10.1182/bloodadvances.2024015596

Published: 2025

Journal Articles

Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma

Leo Meriranta, Rasmus Rask Kragh Jørgensen, Annika Pasanen, Arne Kolstad, Martin Hutchings, Carsten Utoft Niemann, Tarec Christoffer El-Galaly, Jon Riise, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius, Sirpa Leppä, Mats Jerkeman

Blood Adv (2025) 9 (17): 4528–4541.

https://doi.org/10.1182/bloodadvances.2025015791

Published: 2025

Includes: Supplemental data

Journal Articles

Multifaceted cfDNA profiling in mantle cell lymphoma

Brian J. Sworder, Alex F. Herrera

Blood Adv (2025) 9 (17): 4526–4527.

https://doi.org/10.1182/bloodadvances.2025017086

Published: 2025

Journal Articles

Clinical applications of mass spectrometry in multiple myeloma

Benjamin A. Derman, Andrew J. Yee

Blood Adv bloodadvances.2024015685.

https://doi.org/10.1182/bloodadvances.2024015685

Published: 2025

Journal Articles

Early clearance of circulating tumor DNA and association with odronextamab response in relapsed/refractory FL and DLBCL

Jon E Arnason, Matthew J. Matasar, Stefano Luminari, David L Tucker, Dylan Sun, Weiwei Tao, Yuan O Zhu, Kunal Kundu, Namita T Gupta, Allen Leary, Vladimir Jankovic, Srikanth Ambati, Hesham Mohamed, Aafia Chaudhry, Jurriaan Brouwer-Visser

Blood Adv bloodadvances.2025016332.

https://doi.org/10.1182/bloodadvances.2025016332

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of Tranexamic Acid on Postpartum Hemorrhage in Type 1 von Willebrand Disease Treated with Recombinant VWF

Nicoletta Christine Machin, Maria M Brooks, Deborah Vehec, Dana Ivanco, Brandon Lawryk, Craig Daniel Seaman, Frederico Xavier, Sruti Shiva, Angela Verdoni, Margaret V Ragni

Blood Adv bloodadvances.2025017046.

https://doi.org/10.1182/bloodadvances.2025017046

Published: 2025

Includes: Supplemental data

Journal Articles

Acupressure alleviates pain and clinical symptoms in patients with sickle cell disease

Lina Houran, Andrew Q Pucka, Mio Jiang, Ziyue Liu, Andrew RW O'Brien, Steven E Harte, Richard E Harris, Zahra Pakbaz, Ying Wang

Blood Adv bloodadvances.2025016995.

https://doi.org/10.1182/bloodadvances.2025016995

Published: 2025

Includes: Supplemental data

Journal Articles

The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery

Soravis Osataphan, Rushad Patell, Mrigya Babuta, Rachel P. Rosovsky, Yohei Hisada, Charly Edmiston, Pavania Elavalakanar, Michael A. Pfeffer, Amy Bregar, Amanda Ramos, Leslie Garrett, Siyang Ren, Donna Neuberg, Gyongyi Szabo, Robert Flaumenhaft, Nigel Mackman, Meghan Shea, Jeffrey I. Zwicker

Blood Adv (2025) 9 (17): 4472–4476.

https://doi.org/10.1182/bloodadvances.2025016107

Published: 2025

Includes: Supplemental data

Journal Articles

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

Blood Adv (2025) 9 (17): 4396–4404.

https://doi.org/10.1182/bloodadvances.2025016483

Published: 2025

Includes: Supplemental data

Journal Articles

Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study

Ali T. Taher, Vip Viprakasit, Antonis Kattamis, Prof, Silverio Perrotta, Paolo Ricchi, John B. Porter, Thomas D Coates, Gian Luca Forni, Khaled M. Musallam, Oriana Esposito, Richard Pilot, Wen-Ling Kuo, Yinzhi Lai, Marta Reverte, Richard Wei, Luciana Moro Bueno, Maria Domenica Domenica Cappellini

Blood Adv bloodadvances.2025016554.

https://doi.org/10.1182/bloodadvances.2025016554

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia

Efficacy and safety of BCMA nanobody CAR T-cell therapy in relapsed or refractory plasma cell myeloma

Asciminib for relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia

Age-adjusted dosing of fludarabine for lymphodepletion in CAR T-cell therapy: a clinical trial simulation study

Bing-Neel syndrome: a case series of 46 patients from the United Kingdom

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis

A standardized metric to define a successful transition from pediatric to adult care in sickle cell disease

Risk Biomarkers of Chronic Graft-versus-host disease in Children aged 10 years or younger and Children/adults Older than 10 years

Overall survival, conditioning, and MRD in MORPHO

Outcomes following transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from ASPEN

Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma

Multifaceted cfDNA profiling in mantle cell lymphoma

Clinical applications of mass spectrometry in multiple myeloma

Early clearance of circulating tumor DNA and association with odronextamab response in relapsed/refractory FL and DLBCL

Impact of Tranexamic Acid on Postpartum Hemorrhage in Type 1 von Willebrand Disease Treated with Recombinant VWF

Acupressure alleviates pain and clinical symptoms in patients with sickle cell disease

The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only